Search This Blog

Tuesday, March 25, 2025

Stockwatch...Chemtrade Logistics Income Fund Announces Fourth Quarter and Full Year 2024 Financial Results

Stockwatch...Chemtrade Logistics Income Fund Announces Fourth Quarter and Full Year 2024 Financial Results

Business Wire, Feb 28, 2025 12:01 AM EST

Chemtrade Logistics Income Fund Announces Fourth Quarter and Full Year 2024 Financial Results

Reiterates 2025 Guidance for Adjusted EBITDA of Between $430.0 Million and $460.0 Million

Chemtrade Logistics Income Fund (TSX: CHE.UN) (“Chemtrade” or the “Fund”) today announced results for the three- and twelve-month periods ended December 31, 2024. The financial statements and MD&A will be available on Chemtrade’s website at www.chemtradelogistics.com and on SEDAR+ at www.sedarplus.com .

Fourth Quarter 2024 Highlights

  • Revenue of $446.5 million, an increase of $24.5 million or 5.8% year-over-year. Excluding $5.7 million in the prior year period related to the P 2 S 5 business sold in Q4 2023, revenue increased by $30.2 million or 7.3% year-over-year.
  • Adjusted EBITDA (1) of $108.6 million, an increase of $23.9 million or 28.3% year-over-year. Excluding $1.8 million in the prior year period related to the P 2 S 5 business sold in Q4 2023, Adjusted EBITDA increased by $25.7 million or 31.1% year-over-year.
  • Net earnings of $10.3 million, a decrease of $1.4 million year-over-year, primarily due to the gain on sale of the P 2 S 5 business in Q4 2023 offset by higher Adjusted EBITDA.
  • Cash flows from operating activities of $100.0 million, an increase of $1.4 million or 1.4% year-over-year.
  • Distributable cash after maintenance capital expenditures (1) of $39.5 million, an increase of $26.0 million or 192.5% year-over-year.

Full Year 2024 Highlights

  • Revenue of $1,787.0 million, a decrease of $59.7 million or 3.2% year-over-year. Excluding $40.3 million in the prior year period related to the P 2 S 5 business sold in Q4 2023 and a $10.5 million negative impact from the biennial maintenance turnaround at the North Vancouver chlor-alkali facility in 2024, revenue was similar to 2023.
  • Adjusted EBITDA (1) of $470.8 million, the second highest annual Adjusted EBITDA in Chemtrade’s history. Excluding the negative impacts in 2024 from the biennial maintenance turnaround at the North Vancouver chlor-alkali facility ($17.9 million), the work stoppage at the Canadian railways ($5.8 million) and $6.6 million in the prior year period related to the P 2 S 5 business sold in Q4 2023, Adjusted EBITDA earned during 2024 was similar to the record level of Adjusted EBITDA generated during 2023.
  • Net earnings of $126.9 million, a decrease of $122.4 million year-over-year, due to higher net finance costs, unrealized foreign exchange losses, lower Adjusted EBITDA and a gain on sale of the P 2 S 5 business in 2023, partially offset by lower depreciation and amortization expenses.
  • Cash flows from operating activities of $347.8 million, a decrease of $53.7 million or 13.4% year-over-year, primarily due to lower Adjusted EBITDA and changes in working capital, partially offset by lower income taxes paid.
  • Distributable cash after maintenance capital expenditures (1) of $213.1 million, a decrease of $69.9 million or 24.7% year-over-year, reflecting lower cash flows from operating activities and higher lease payments.
  • During 2024, Chemtrade returned $131.1 million of capital to unitholders in the form of unit buybacks under its NCIB and monthly distributions. This represented 61.5% of Distributable cash after maintenance capital expenditures (1) .
  • Maintained a strong balance sheet throughout 2024, with a Net debt to LTM Adjusted EBITDA (1) ratio of 1.8x at 2024 year-end. Chemtrade took several actions during 2024 to optimize its capital structure, including completing a substantial issuer bid (SIB) for its Fund 2020 8.50% debentures and redeeming the remaining Fund 2020 8.50% debentures subsequent to the completion of the SIB. Chemtrade also issued Notes with an aggregate principal amount of $250.0 million with a coupon of 6.375% and a due date of August 28, 2029.
  • In January 2024, Chemtrade increased its monthly distribution rate by 10% to $0.055 per unit or $0.660 per unit per year. Chemtrade’s Payout ratio (1) for 2024 was 37%. Subsequent to year-end, in January 2025, Chemtrade increased its monthly distribution rate by approximately 5% to $0.0575 per unit or $0.690 per unit per year.
  • In June 2024, Chemtrade commenced a normal course issuer bid (NCIB), under which the Fund is authorized to purchase up to approximately 11.7 million of its units. As of December 31, 2024, approximately 5.1 million units were purchased as part of the NCIB.
  • Chemtrade reaffirms its 2025 Adjusted EBITDA guidance of $430.0 million to $460.0 million. Achieving the midpoint of this range would mark the third-highest annual Adjusted EBITDA in Chemtrade’s history.

(1) Adjusted EBITDA is a Total of Segments measure, Distributable cash after maintenance capital expenditures is a non-IFRS measure and Net debt to LTM Adjusted EBITDA and Payout ratio are Non-IFRS ratios. Please see Non-IFRS and Other Financial Measures for more information.

Scott Rook, President and CEO of Chemtrade, commented on the fourth quarter and full year 2024 results, “2024 was another year of strong financial and operational performance for Chemtrade, delivering the second highest annual Adjusted EBITDA result in our history. We are particularly encouraged by the growth in our water products, where profitability has almost doubled over the last three years. Our ability to deliver strong performance, despite a dynamic operating environment, reflects the resilience of our business, the strength of our strategy, and the passion of our team. With consistent execution and our ongoing focus on operational excellence, we continued to generate strong cash flow, supporting our ability to invest in strategic growth, further strengthen our competitive position, and return capital to unitholders through our attractive distribution and the NCIB we instituted during the year.”

“Looking ahead, we are well-positioned to build on this momentum. Our track-record of investing in high-return projects to drive organic growth has yielded strong results, as is evident in our water chemicals business. In terms of individual products, water chemicals was the largest contributor to our consolidated Adjusted EBITDA in 2024, and this business line’s stability, paired with a long-term growth trend makes it core to our strategy moving forward. Our key growth areas of water chemicals and ultrapure acid continue to have strong outlooks, and we are acting on opportunities to expand our leadership in these product lines. Many of our other core product lines continue to provide us with a stable foundation and contribute to the resilience of our earnings. With respect to our North Vancouver chlor-alkali facility, we continue to have active lease negotiations with the Vancouver Fraser Port Authority. The next step for us it to go through the rezoning process with the District of North Vancouver, which is required in order for us to obtain approval to proceed with our planned safety improvements for the site. We look forward to sharing additional updates on this process as they become available.”

“We enter 2025 on strong footing with a clear strategy to generate long-term unitholder value. The earnings power of our business has taken a notable step-change in recent years, and we remain diligently focused on leveraging all of the tools at our disposal to deliver strong total unitholder returns. With a sharp strategic focus, a strong balance sheet, and a dedicated team, we are confident in our ability to navigate an evolving market and deliver value for our unitholders well into the future.”

Consolidated Financial Summary of Q4 2024

Revenue for the fourth quarter of 2024 was $446.5 million, compared to $422.0 million in the fourth quarter of 2023. Excluding $5.7 million of revenue in the prior year period from the P 2 S 5 business sold in the fourth quarter of 2023, consolidated revenue increased by $30.2 million or 7.3% year-over-year. This increase was primarily due to: (i) higher volumes of water solutions products and higher selling prices for Regen and merchant acid in the Sulphur and Water Chemicals (SWC) segment; and (ii) higher selling prices for caustic soda, HCl, chlorine, and sodium chlorate in the Electrochemicals (EC) segment. These factors were partially offset by lower sales volumes of sodium chlorate, which more than offset the higher selling prices for sodium chlorate in the EC segment.

Adjusted EBITDA for the fourth quarter of 2024 was $108.6 million, compared to $84.6 million in the fourth quarter of 2023. Excluding $1.8 million of Adjusted EBITDA in the prior year period related to the P 2 S 5 business sold in the fourth quarter of 2023, Adjusted EBITDA increased by $25.7 million or 31.1% year-over-year. This increase was primarily due to: (i) lower input costs resulting in improved margins for water solutions products, improved margins for sodium nitrite as 2023 experienced higher costs, and higher pricing for Regen and merchant acid in the SWC segment; and (ii) higher selling prices for caustic soda, HCl, chlorine, and sodium chlorate in the EC segment. Partial offsets to the above positive factors included: (i) lower sales volumes of sodium chlorate in the EC segment; and (ii) higher Corporate costs due mainly to realized foreign exchange losses.

Distributable cash after maintenance capital expenditures for the fourth quarter of 2024 was $39.5 million or $0.33 per unit, compared with $13.5 million or $0.12 per unit in the fourth quarter of 2024. This increase primarily reflects the same factors that impacted Adjusted EBITDA, as noted above, as well as lower maintenance capital expenditures, partially offset by higher lease payments. Chemtrade’s Payout ratio (1) for the twelve months ended December 31, 2024 was 37%.

Chemtrade maintained a strong balance sheet through the fourth quarter of 2024. As of December 31, 2024, Chemtrade’s Net debt was $864.2 million and its Net debt to LTM Adjusted EBITDA ratio was 1.8x. As of the end of 2024, Chemtrade also maintained strong financial liquidity with US$521.5 million undrawn on its credit facilities, in addition to $25.5 million of cash on hand.

Segmented Financial Summary of Q4 2024

The SWC segment reported revenue of $260.1 million for the fourth quarter of 2024, compared to $243.8 million for the fourth quarter of 2023. Adjusted EBITDA in the SWC segment was $62.5 million for the fourth quarter of 2024, compared to $40.8 million for the fourth quarter of 2023. The P 2 S 5 business that was sold in the fourth quarter of 2023 contributed $5.7 million of SWC revenue and $1.8 million of SWC Adjusted EBITDA in the fourth quarter of 2023.

Excluding the impact of the P 2 S 5 business as noted above, SWC revenue in the fourth quarter of 2024 increased by $22.0 million or 9.2% year-over-year. The increase in comparable SWC revenue was primarily due to: (i) higher volumes of water solutions products; and (ii) higher selling prices and volumes for merchant and Regen acid. Excluding the impact of the P 2 S 5 business as noted above, SWC Adjusted EBITDA increased by $23.5 million or 60.2% year-over-year. The increase in comparable SWC Adjusted EBITDA was primarily due to: (i) lower input costs resulting in an improvement in margins for water solutions products; (ii) an improvement in margins for sodium nitrite relative to 2023, as that period was affected by lower volumes due to an extended turnaround and disposal costs for a related by-product; and (iii) higher selling prices for Regen and merchant acid.

The EC segment reported revenue of $186.4 million for the fourth quarter of 2024, compared to $178.2 million for the fourth quarter of 2023. Adjusted EBITDA in the EC segment was $83.5 million for the fourth quarter of 2024, compared to $73.3 million for the fourth quarter of 2023.

EC revenue in the fourth quarter of 2024 increased by $8.2 million or 4.6% year-over-year, primarily due to higher realized MECU netbacks of approximately $230 year-over-year, with HCl and chlorine accounting for approximately 55% of the improvement. A partial offset to EC revenue growth was lower sales volumes of sodium chlorate, which more than offset higher selling prices for sodium chlorate. EC Adjusted EBITDA increased by $10.2 million or 13.9% year-over-year. The factors that affected EC revenue also had an impact on EC’s Adjusted EBITDA on a year-over-year basis.

Corporate costs for the fourth quarter of 2024 were $37.3 million, compared with $29.4 million in the fourth quarter of 2023. The increase in corporate costs was primarily due to the inclusion of $7.4 million of realized foreign exchange losses in the fourth quarter of 2024 compared with $0.2 million of realized foreign exchange gains in the fourth quarter of 2023. Excluding realized foreign exchange gains and losses, corporate costs were similar on a year-over-year basis, with lower legal and other costs partially offset by $2.1 million of higher incentive compensation costs.

Update on Organic Growth Projects

Chemtrade remains focused on its long-term objective of delivering sustained earnings growth and generating value for investors. To accomplish this, Chemtrade has identified various organic growth initiatives. In 2025, Chemtrade plans to invest between $40.0 million and $60.0 million in growth capital expenditures, which includes expansions of water treatment chemicals, upgrades to ultrapure sulphuric acid production, and other organic growth projects.

Construction of the Cairo, Ohio ultrapure acid project is now complete and the project is in the startup process. The commercial ramp up will begin to take place in 2025. This will be one of the first ultrapure sulphuric acid plants in North America that is expected to meet the quality requirements for next generation semiconductor nodes. This project will further bolster Chemtrade’s position as a leading North American supplier of ultrapure sulphuric acid to the semiconductor industry.

Chemtrade also previously identified a second large ultrapure sulphuric acid growth project, undertaken via a joint venture with KPCT Advanced Chemicals LLC and located in Casa Grande, AZ. Together with its joint venture partner, Chemtrade made the decision to put the project on hold until it can be assured the project generates an acceptable level of return.

Distributions and Capital Allocation Update

Distributions declared in the fourth quarter of 2024 totalled $0.165 per unit, comprised of monthly distributions of $0.055 per unit, which reflects a 10% increase in the monthly distribution rate beginning with the distribution declared during the month of January 2024. This distribution was well-covered by Chemtrade’s cash flow generation during 2024, with a Payout ratio in 2024 of 37%.

In January 2025, Chemtrade announced an additional increase to its monthly distribution by approximately 5% to 5.75 cents per month, effective with the distribution declared during the month of January 2025. This distribution represents a Payout ratio of 48% based on the mid-point of Chemtrade’s guidance for 2025. The increase in the level of cash distributions is expected to have a minimal impact on Chemtrade’s leverage and is not expected to impede Chemtrade’s ability to execute growth initiatives while maintaining a healthy balance sheet.

Chemtrade’s balance sheet has continued to improve in recent years, with a Net debt to LTM Adjusted EBITDA of 1.8x at December 31, 2024. Chemtrade’s business has also strengthened as evidenced by the last three years representing the three highest years for Adjusted EBITDA in Chemtrade’s history.

Chemtrade implemented an NCIB, under which Chemtrade is authorized to purchase up to 11.7 million units over a 12-month period ending June 2, 2025. As of December 31, 2024, approximately 5.1 million units were purchased as part of the NCIB, representing roughly 4% of its units outstanding. For the period from January 1, 2025 to February 26, 2025, an additional 2.7 million units were purchased by the Fund under the NCIB’s automatic share purchase plan. Purchases of units are effected through the facilities of the TSX and/or alternative Canadian trading systems and are made by means of open market transactions, or such other means as may be permitted by the TSX, including block purchases of units, at prevailing market rates. The timing and amount of any purchases are subject to management’s discretion.

During January 2025, Chemtrade issued an additional $125.0 million aggregate principal amount of 6.375% Notes due August 28, 2029, resulting in an aggregate principal amount of $375.0 million outstanding on these Notes. The Fund incurred transaction costs of $2.5 million. The Fund will utilize the net proceeds of the issuance to reduce indebtedness and for general corporate purposes.

Chemtrade’s management and Board of Trustees continue to assess opportunities to further adjust and optimize Chemtrade’s capital structure and capital allocation. This could potentially include supplementing its organic growth initiatives with modest M&A, should Chemtrade identify an opportunity that fits strategically within its portfolio and has synergistic value. The acquisitions Chemtrade would target would primarily be those with annual Adjusted EBITDA in the $10.0 - $50.0 million range.

Rohit Bhardwaj, CFO of Chemtrade, commented on Chemtrade’s capital allocation, “As we close out a successful 2024 and begin 2025, we remain committed to a disciplined and unitholder-friendly capital allocation strategy that balances capital returns to unitholders, strategic growth investments and financial prudence. During 2024, we returned $131.1 million of capital to unitholders, representing 61.5% of our Distributable cash after maintenance capital expenditures. We remain focused on high-return opportunities that enhance our long-term earnings potential, while preserving financial flexibility. In line with this approach, we continue to invest in our key growth areas, including water chemicals and ultrapure acid, fully funded through internally generated cash flow and available credit. At the same time, we are committed to delivering sustainable returns to our unitholders through a balanced mix of distributions and unit purchases under our NCIB. We have also taken proactive steps over the past year to strengthen our balance sheet, reducing near-term debt obligations, optimizing our capital structure, enhancing liquidity and aggressively reducing potentially dilutive debt instruments. By extending debt maturities and securing more favourable financing, Chemtrade is well-positioned to navigate market conditions while maintaining the flexibility to pursue strategic, value generating opportunities. Looking ahead, we will continue to take a thoughtful approach to capital deployment, ensuring that we create long-term value for our unitholders while maintaining financial strength.”

Statement on potential US tariffs

The current US administration has stated its intention to levy a 25% tariff on Canadian products being exported to the US effective March 1, 2025. The tariffs being contemplated are unprecedented and it is difficult to estimate the impact on the overall economy, Chemtrade’s suppliers and customers.

There are three main products in the portfolio that are imported into the US from Canada – sodium chlorate, chlorine, and merchant sulphuric acid. If these products are subject to tariffs, Chemtrade will work diligently to mitigate their impact, including by passing these costs on to US customers. While Chemtrade is optimistic that it will be successful in passing a significant portion of the costs to customers, this situation is without precedence. Chemtrade’s success would depend upon, among other things, the impact of tariffs on customers' businesses and industry dynamics in the US.

Chemtrade benefits from a weaker Canadian dollar relative to the US dollar, which could be a potentially mitigating factor. The current exchange rate of approximately US$1 = C$1.44 is weaker than the exchange rate assumed in Chemtrade’s above noted 2025 guidance. Chemtrade discloses its sensitivity to exchange rates, as well as its foreign exchange hedge positions in its Management’s Discussion and Analysis document.

About Chemtrade

Chemtrade operates a diversified business providing industrial chemicals and services to customers in North America and around the world. Chemtrade is one of North America’s largest suppliers of sulphuric acid, spent acid processing services, inorganic coagulants for water treatment, sodium chlorate, sodium nitrite and sodium hydrosulphite. Chemtrade is also a leading producer of high purity sulphuric acid for the semiconductor industry in North America. Chemtrade is a leading regional supplier of sulphur, chlor-alkali products, and zinc oxide. Additionally, Chemtrade provides industrial services such as processing by-products and waste streams.

----------------------------

Source

https://money.tmx.com/quote/CHE.UN/news/6669375551558905/Chemtrade_Logistics_Income_Fund_Announces_Fourth_Quarter_and_Full_Year_2024_Financial_Results


Thursday, March 20, 2025

Stockwatch...Stella-Jones Announces Fourth Quarter and Year-End Results

Stockwatch...Stella-Jones Announces Fourth Quarter and Year-End Results

GlobeNewswireFeb 27, 2025 7:00 AM EST

Stella-Jones Announces Fourth Quarter and Year-End Results

Company Focused on Sustained Profitable Growth
  • Annual sales of $3,469 million , up 5% vs the prior year
  • Operating income of $503 million
  • EBITDA (1) of $633 million, or 18.2% margin (1)
  • EPS of $5.66, compared to $5.62 in 2023
  • Strong operating cash flow of $408 million
  • Increasing quarterly dividend by 11% to $0.31 per share
  • Reaffirms 2023-2025 financial objectives

MONTREAL, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced financial results for its fourth quarter and year ended December 31, 2024.

“We concluded another year of sales and EBITDA growth, reflecting the enduring strength of our business and unwavering customer-centric approach,” said Eric Vachon, President and Chief Executive Officer of Stella-Jones. “We achieved solid results in our infrastructure product categories, even in the face of softer market demand for utility poles. We acquired new customers, maintained our expanded EBITDA margin of over 18%, and delivered strong operating cashflows. Given our conviction in the long-term fundamentals of our business, we have also increased the quarterly dividend for the 21 st consecutive year.”

“As we turn to 2025, we remain confident in the growth prospects of our current infrastructure business, supported by the accelerated need to strengthen North America’s aging electrical grid, and the opportunities in railway ties to drive increased profitability. We also look to build even stronger customer relationships by expanding our offering to our infrastructure customers. As we drive forward, we will continue to focus on optimizing our operating model and generating a healthy EBITDA margin. With our strong cash flow-generating business and disciplined capital allocation strategy, we are confident that our actions will continue to enhance shareholder value.”

Financial Highlights
(in millions of Canadian dollars, except ratios and per share data)


Three-month periods
ended 
December 31 ,
Years
ended December 31 ,
2024202320242023
Sales7306883,4693,319
Gross profit (1)138137724688
Gross profit margin (1)18.9%19.9%20.9%20.7%
Operating income8189503499
Operating income margin (1)11.1%12.9%14.5%15.0%
EBITDA (1)115120633608
EBITDA margin (1)15.8%17.4%18.2%18.3%
Net income5256319326
Earnings per share (“EPS”) - basic and diluted0.930.985.665.62
Weighted average shares outstanding (basic, in ‘000s)55,96657,07656,40357,963
Net debt-to-EBITDA (1)2.6x2.6x

(1) These indicated terms have no standardized meaning under GAAP and are not likely to be comparable to similar measures presented by other issuers. For more information, please refer to the section entitled “Non-GAAP and Other Financial Measures” of this press release for an explanation of the non-GAAP and other financial measures used and presented by the Company and a reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures.

FOURTH QUARTER RESULTS

Sales for the fourth quarter of 2024 amounted to $730 million, up 6% from sales of $688 million for the same period in 2023. Excluding the currency conversion of $14 million, pressure-treated wood sales rose $31 million, or 5% due to higher railway ties sales attributable to an increase in Class 1 volumes and improved residential lumber sales, while utility poles sales were relatively unchanged. Lower logs and lumber sales were driven by a decrease in log sales activity, compared to the fourth quarter last year.

Pressure-treated wood products:

  • Utilit y poles (53% of Q4-24 sales) : Utility poles sales totaled $385 million in the fourth quarter of 2024, compared to sales of $383 million in the corresponding period last year. Excluding the currency conversion effect, sales decreased by 2%, due to lower volumes from non-contract business, offset in large part by favourable price adjustments to cover increased costs.
  • Railway ties (26% of Q4-24 sales) : Sales of railway ties amounted to $193 million, compared to $165 million in the same period last year. Excluding the currency conversion effect, railway ties sales rose 15%, largely explained by the timing of Class 1 shipments. For the year, Class 1 volumes increased modestly when compared to 2023.
  • Residen tial lumber (13% of Q4-24 sales) : Residential lumber sales totaled $93 million, up from $82 million of sales generated in the same period in 2023, reflecting a 12% organic sales growth. The increase in residential lumber sales stemmed from favourable pricing attributable to the increase in the market price of lumber, as well as higher sales volumes, when compared to the same period last year.
  • Industrial produc ts (4% of Q4-24 sales) : Industrial products sales amounted to $31 million, up from $27 million last year. The organic sales growth of 11% was mainly attributable to higher sales for railway bridges and crossings.

Logs and lumber:

  • Logs and lumber (4% of Q4-24 sales) : Logs and lumber sales totaled $28 million, down 10% compared to the same period last year.

Gross profit was $138 million in the fourth quarter of 2024, relatively unchanged compared to the gross profit of $137 million in the fourth quarter of 2023. As a percentage of sales, gross profit decreased from 19.9% in the fourth quarter of 2023 to 18.9% in the fourth quarter of 2024 due to a less favourable sales mix.

Net income for the period amounted to $52 million, or $0.93 per share, compared with $56 million, or $0.98 per share, in the corresponding period of 2023.

2024 RESULTS

Sales for the year ended December 31, 2024 reached $3,469 million, up 5%, versus sales of $3,319 million in 2023. Excluding the contribution from the acquisition of the Baldwin assets of $25 million and the currency conversion effect of $36 million, pressure-treated wood sales rose $110 million, or 3%. Infrastructure sales, namely utility poles, railway ties and industrial products, grew organically by $144 million or 6%, while residential lumber sales decreased by $34 million. Favourable pricing across all the infrastructure product categories and higher railway ties volumes were partially offset by lower volumes for utility poles and residential lumber. The decrease in logs and lumber sales compared to last year was largely attributable to less logs sales.

Pressure-treated wood products:

  • Utility poles (49% of 2024 sales) : Utility poles sales increased to $1,705 million in 2024, compared to sales of $1,571 million in 2023. Excluding the contribution from the acquisition of assets of Baldwin in July 2023 and the currency conversion effect, utility poles sales increased by $88 million, or 6%, driven by sales price adjustments to cover increased costs. This increase was offset in part by lower volumes when compared to last year. Incremental multi-year commitments were secured from new and existing customers but volumes were impacted by the slower pace of purchases and a deferral in the execution of projects by utilities, largely influenced by economic factors, including inflation and utilities’ supply chain constraints, as well as timing of utilities’ rate-based funding.
  • Railway ties (26% of 2024 sales) : Railway ties sales were $890 million in 2024, compared to sales of $828 million in 2023. Excluding the currency conversion effect, railway ties sales increased $51 million, or 6%. The increase was attributable to higher volumes, mainly for non-Class 1 business due to the replenished level of railway ties inventory, as well as improved pricing, when compared to last year.
  • Residential lumber (18% of 2024 sales) : Sales in the residential lumber category decreased to the lower end of the Company's $600 to $650 million target range for this product category, at $614 million in 2024, compared to sales of $645 million in 2023. Excluding the currency conversion effect, residential lumber sales decreased $34 million, or 5%, all explained by lower sales volumes due to softer consumer demand. The average market price of lumber remained relatively unchanged in 2024 when compared to 2023.
  • Industrial products (4% of 2024 sales) : Industrial products sales were $154 million in 2024 compared to sales of $148 million in 2023. Excluding the currency conversion effect, industrial product sales increased five million dollars, or 3%, mainly driven by higher sales for railway bridges and crossings.

Logs and lumber:

  • Logs and lumber (3% of 2024 sales) : Sales in the logs and lumber product category were $106 million in 2024, down from $127 million in 2023. The decrease in sales was explained by less logs sales activity.

Gross profit increased to $724 million in 2024, compared to $688 million in 2023, representing a margin of 20.9% and 20.7% respectively. Similarly, EBITDA increased to $633 million in 2024 compared to $608 million in 2023, largely due to the sales growth of the Company’s infrastructure product categories. EBITDA margin remained relatively unchanged at 18.2% in 2024, compared to 18.3% in 2023.

Net income in 2024 was $319 million, compared to net income of $326 million in 2023. Despite the lower net income, earnings per share in 2024 was higher at $5.66 versus $5.62 in 2023 due to the continued repurchase of shares through the Company’s normal course issuer bids.

LIQUIDITY AND CAPITAL RESOURCES

During the year ended December 31, 2024, Stella-Jones used the cash generated from operations of $408 million to invest in its network as well as return $153 million to shareholders. In 2024, the Company invested a net amount of $88 million to maintain its assets and enhance productivity and $34 million to complete its growth investments for utility poles. Over the 2022 to 2024 period, approximately $130 million was invested in growth capital expenditures. The dividend paid in 2024 amounted to $1.12 per share, representing a 22% increase compared to 2023. As at December 31, 2024, the Company had returned to shareholders $348 million out of the $500 million committed for the 2023 to 2025 period.

As at December 31, 2024, the Company maintained a healthy financial position with available liquidity of $802 million. Its net debt-to-EBITDA ratio stood slightly above the target range at 2.6x, as the appreciation of the closing rate of the U.S. dollar relative to the Canadian dollar resulted in a higher value of the Company’s net debt denominated in U.S. dollars, when expressed in Canadian dollars.

Subsequent to year-end, the Company amended the U.S. Farm Credit Agreement in order to, among other things, extend the term of the Revolving Credit Facility of US$150 million from March 3, 2028 to February 4, 2030.

REAFFIRMING 2023-2025 FINANCIAL OBJECTIVES

The following is a summary of the Company’s 2023-2025 financial objectives:

(in millions of dollars, except percentages and ratios)2023-2025 Objectives
Salesapprox . $3,600
EBITDA margin> 17%
Return to Shareholders: cumulative> $500
Net Debt-to-EBITDA2.0x-2.5x


The Company assumed that the Canadian dollar will trade, on average, at Can $1.36 per U.S. dollar for 2025.

QUARTERLY DIVIDEND INCREASED 11% TO $0.31 PER SHARE

On February 26, 2025, the Board of Directors declared a quarterly dividend of $0.31 per common share payable on April 18, 2025 to shareholders of record at the close of business on April 1, 2025. This dividend is designated to be an eligible dividend.

ABOUT STELLA-JONES

Stella-Jones Inc. (TSX: SJ) is a leading North American manufacturer of products focused on supporting infrastructure that are essential to the delivery of electrical distribution and transmission, and the operation and maintenance of railway transportation systems. It supplies the continent’s major electrical utilities companies with treated wood utility poles and North America’s Class 1, short line and commercial railroad operators with treated wood railway ties and timbers. It also supports infrastructure with industrial products, namely timbers for railway bridges, crossings and construction, marine and foundation pilings, and coal tar-based products. Additionally, the Company manufactures and distributes premium treated residential lumber and accessories to Canadian and American retailers for outdoor applications, with a significant portion of the business devoted to servicing Canadian customers through its national manufacturing and distribution network.

----------------------------------------
Source

https://money.tmx.com/quote/SJ/news/8583169465004134/StellaJones_Announces_Fourth_Quarter_and_YearEnd_Results

Monday, March 17, 2025

Stockwatch...Whitecap Resources and Veren to Combine in a $15 Billion Transaction to create a leading Canadian Light Oil AND Condensate Producer

Stockwatch...Whitecap Resources and Veren to Combine in a $15 Billion Transaction to create a leading Canadian Light Oil AND Condensate Producer

Canada Newswire, Mar 10, 2025 6:00 AM EDT

CALGARY, AB , March 10, 2025 /CNW/ - Whitecap Resources Inc. ("Whitecap") (TSX: WCP) and Veren Inc. ("Veren") (TSX: VRN) (NYSE: VRN) are pleased to announce a strategic combination to create a leading light oil and condensate producer with concentrated assets in the Alberta Montney and Duvernay . The combined company will be the largest Alberta Montney and Duvernay landholder, a prominent light oil producer in Saskatchewan and will leverage the combined asset base and technical expertise to drive improved profitability and superior returns to shareholders.

The companies have entered into a definitive business combination agreement (the "Agreement") to combine in an all-share transaction valued at approximately $15 billion , inclusive of net debt 1 . Under the terms of the Agreement, Veren shareholders will receive 1.05 common shares of Whitecap for each Veren common share held. The combined company will be led by Whitecap's existing management team under the Whitecap name with four Veren directors to join the Whitecap Board of Directors, including the current President & CEO of Veren, Craig Bryksa . The transaction is expected to close before May 30, 2025 .

Grant Fagerheim , Whitecap's President & CEO, stated: "We are excited to bring together two exceptionally strong asset bases to create one world-class energy producer with one of the deepest inventory growth sets of both liquids-rich Montney and Duvernay opportunities, along with conventional light oil opportunities in some of the most profitable plays in the Western Canadian basin. Our combined company will include exceptional technical and support personnel from the two companies in both the office and field and an experienced Board of Directors that prioritizes sustainable and profitable growth to generate strong returns for our combined shareholders. We look forward to bringing Whitecap and Veren together and providing increased value to both sets of shareholders well into the future."

Craig Bryksa , Veren's President & CEO, stated, "This strategic combination unlocks significant value for all shareholders and together positions us as a stronger, more resilient company. With enhanced scale, deep inventory, and increased free funds flow generation, we're building a business with a differentiated competitive advantage. Our combined balance sheet reinforces our financial strength and enhanced credit profile, ensuring the long-term success in an evolving market. Together we're unlocking synergies, creating new opportunities, and setting the stage for sustainable growth."

Strategic Rationale

  • Solidified Position Within the Large-Cap Universe: The combined company will have an enterprise value of $15 billion 1 and 370,000 boe/d 2 (63% liquids) of corporate production with significant overlap across both unconventional and conventional assets. The combined company becomes the largest Canadian light oil focused producer and the seventh largest producer in the Western Canadian Sedimentary Basin, with significant natural gas growth potential.

  • Significant Size and Scale across the High Impact Montney and Duvernay : The combined company becomes the largest producer in the high margin Kaybob Duvernay and Alberta Montney with approximately 220,000 boe/d of unconventional production. The combined company becomes the largest landholder in the Alberta Montney and the second largest landholder across unconventional Montney and Duvernay fairways with 1.5 million acres in Alberta . The combined company boasts over 4,800 total development locations 3 in the Montney and Duvernay to drive decades of future production growth.

  • Leading Low Decline Light Oil Position in Saskatchewan : The combined company becomes the second largest producer in Saskatchewan with consolidated assets in west and southeast Saskatchewan . The combined business will have 40% of its conventional production under waterflood recovery supporting a decline rate of less than 20% on 150,000 boe/d of production. These foundational assets have approximately 7,000 development locations to support meaningful free funds flow generation into the future.

  • Immediate Accretion: The combination is immediately accretive to Whitecap standalone funds flow per share 1 (10%) and free funds flow per share 1 (26%), before incorporating any benefit from expected synergies, highlighting increasing sustainability and an enhanced financial outlook for the combined shareholders.

  • Visible Long-Term Synergies: Visible operating, capital and corporate synergies which, in addition to supply chain efficiencies, can generate meaningful savings. Anticipated annual synergies of over $200 million can be achieved independent of commodity prices and will begin to be captured upon closing of the transaction.

  • Strong Credit Profile: Exceptional balance sheet with initial leverage of 0.9 times Net Debt to Funds Flow 1 which is expected to continue to further strengthen to 0.8 times by year end 2026. Whitecap and Veren both have an investment grade credit rating of BBB (low), with a Stable trend, issued by DBRS, Inc. ("Morningstar DBRS") and with the strength and increased scale of the combined company the credit profile is expected to improve, which has the potential to reduce the go-forward cost of debt and expand debt marketing opportunities.

  • Pathway for Long-Term Growth and Value Creation: Reaching critical mass that is desirable in public markets increases the potential to expand the combined company's shareholder base and achieve a greater market following. Pro forma scale, risk profile and increased market relevance is expected to drive multiple expansion to valuations that are more closely aligned with the large-cap peers. The combined company will continue to pay Whitecap's annual dividend of $0.73 per share, representing a 67% increase in base dividend for Veren shareholders.

  • Disciplined Leadership and Governance: The combined business will continue to be led by the Whitecap executive team, who have a long track record of operational excellence, financial discipline, strong safety performance and are focused on generating strong returns to shareholders. The Board of Directors will consist of eleven members, made up of seven directors from Whitecap and four directors from Veren.

Financial Summary

The combined company's production forecast at closing is 370,000 boe/d (63% liquids) and based on commodity prices of US$70 /bbl WTI and C$2.00 /GJ AECO, the forecast annualized funds flow is $3.8 billion 1 . After annual capital investments of $2.6 billion 4 , free funds flow is forecast at $1.2 billion 1 . Detailed 2025 guidance will be provided on close of the transaction.

Concurrent with entering into the Agreement, Whitecap has received commitments from National Bank of Canada ("NBC") and the Toronto Dominion Bank ("TD") with National Bank Financial Markets and TD Securities, as Joint Bookrunners and Co-Lead Arrangers, for a $500 million increase to the company's existing committed $2.0 billion credit facilities as well as commitments for an additional fully committed $1.0 billion credit facility from NBC, TD, Bank of Montreal , and Bank of Nova Scotia as Joint Bookrunners. On a combined basis, these facilities provide for $3.5 billion in total credit capacity available to Whitecap on closing to support the combination.

Combination Structure Details

The companies have entered into the Agreement to combine in an all-share transaction valued at approximately $15 billion , inclusive of net debt. Under the terms of the Agreement, Veren shareholders will receive 1.05 common shares of Whitecap for each common share of Veren held. Following the close of the transaction, Whitecap shareholders will own approximately 48% and Veren shareholders will own approximately 52% of the total common shares outstanding of the combined company.

It is anticipated that normal course monthly dividend payments will continue to be made by Whitecap and that Veren's first quarter dividend will be paid in the normal course, after which Veren will not pay dividends, provided that, in the event that the transaction closes after May 31, 2025 , Veren shareholders will be entitled to a Special Dividend comprised of a monthly dividend declared by the Veren Board and paid by Veren in respect of the month of May and every calendar month thereafter in which the Effective Date does not occur, in the amount of $0.03833 per Veren share (being one-third of Veren's current quarterly dividend per Veren share).

The transaction is structured through a plan of arrangement in respect of the securities of Veren under the Business Corporations Act ( Alberta ) and is subject to the approval of at least two-thirds of the votes cast by holders of Veren common shares. The issuance of Whitecap common shares pursuant to the arrangement is subject to the approval of the majority of votes cast by holders of Whitecap common shares in connection with the transaction. Closing of the transaction will be subject to approval of the arrangement by the Court of King's Bench of Alberta as well as other customary closing conditions, including the receipt of customary regulatory and Toronto Stock Exchange approvals. The transaction is expected to close before May 30, 2025 .

An independent special committee (the "Special Committee") of the Board of Directors of Veren was formed to consider and review the transaction on behalf of the Veren Board of Directors. Based on, among other things, the unanimous recommendation of the Special Committee, the Board of Directors of Veren unanimously determined that the transaction and the entering into of the Agreement are in the best interests of Veren, the transaction is fair to the Veren shareholders and approved the Agreement, and has unanimously recommended that Veren shareholders vote in favor of the resolution to approve the transaction at the special meeting of Veren shareholders to be held on or about May 6, 2025 .

The Board of Directors of Whitecap unanimously determined that the transaction and the entering into of the Agreement are in the best interests of Whitecap, the transaction is fair to the Whitecap shareholders and approved the Agreement, and has unanimously recommended that Whitecap shareholders vote in favour of the resolution to approve the issuance of Whitecap common shares pursuant to the transaction at the special meeting of Whitecap shareholders to be held on or about May 6, 2025 .

A joint information circular, which will include details of the transaction, is expected to be mailed to Whitecap and Veren shareholders in mid-April 2025 .

Advisors

National Bank Financial Inc. and TD Securities acted as financial advisors to Whitecap. National Bank Financial has provided a verbal opinion to Whitecap that the exchange ratio under the plan of arrangement is fair, from a financial point of view to the Whitecap shareholders and is subject to the assumptions made and the limitations and qualifications in the written opinion of National Bank Financial. Burnet, Duckworth & Palmer LLP is acting as Whitecap's legal advisor for the transaction.

BMO Capital Markets is acting as financial advisor to Veren, and Scotiabank is acting as financial advisor to the Special Committee of Veren. BMO Capital Markets and Scotiabank have each provided a verbal opinion to the Veren Board of Directors and the Special Committee, respectively, that the exchange ratio under the plan of arrangement is fair, from a financial point of view to the Veren shareholders and is subject to the assumptions made and the limitations and qualifications in the written opinions of BMO Capital Markets and Scotiabank. Norton Rose Fulbright Canada LLP is acting as Veren's legal advisor for the transaction and Blake, Cassels & Graydon LLP is acting as legal advisor to the Special Committee.

CONFERENCE CALL AND WEBCAST

Whitecap and Veren will be hosting a joint conference call and webcast to discuss the transaction and will begin promptly at 6:30 am MT ( 8:30 am ET ) on Monday, March 10, 2025 .

The conference call dial-in number is: 1-888-510-2154 or (403) 910-0389 or (437) 900-0527

A live webcast of the conference call will be accessible on Whitecap's website at www.wcap.ca and Veren's website at www.vrn.com by selecting "Investors" , then "Presentations & Events" . Shortly after the live webcast, an archived version will be available on the companies' websites. A presentation regarding the strategic combination of Whitecap and Veren is available on Whitecap's website at www.wcap.ca .

------------------------
Source

https://money.tmx.com/quote/WCP/news/8955248433354729/WHITECAP_RESOURCES_AND_VEREN_TO_COMBINE_IN_A_15_BILLION_TRANSACTION_TO_CREATE_A_LEADING_CANADIAN_LIGHT_OIL_AND_CONDENSATE_PRODUCER